Literature DB >> 11591854

Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome.

I Eisensehr1, T C Wetter, R Linke, S Noachtar, H von Lindeiner, F J Gildehaus, C Trenkwalder, K Tatsch.   

Abstract

Fourteen drug-naive and 11 levodopa-treated patients with idiopathic restless legs syndrome (RLS), and 10 controls age-matched to each RLS group separately were examined with polysomnography (PSG), [(123)I]-(N)-(3-iodopropen-2-yl)-2beta-carbomethoxy-3beta-(4-chlorophenyl) tropane ((123)I-IPT) SPECT, and [(123)I]-(S)-2-hydroxy-3-iodo-6-methoxy-[(1-ethyl-2-pyrrolidinyl)methyl] benzamide ((123)I-IBZM) SPECT. Drug-naive and levodopa-treated patients with RLS and controls showed similar striatal dopamine transporter and dopamine D(2)-receptor binding, the latter declining with age. The authors conclude that striatal dopamine transporter and receptor density is normal in drug-naive and levodopa-treated patients with RLS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591854     DOI: 10.1212/wnl.57.7.1307

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Basal cardiac autonomic tone is normal in patients with periodic leg movements during sleep.

Authors:  Jose-Alberto Palma; Manuel Alegre; Miguel Valencia; Julio Artieda; Jorge Iriarte; Elena Urrestarazu
Journal:  J Neural Transm (Vienna)       Date:  2013-11-16       Impact factor: 3.575

Review 2.  [Neurophysiological and neuroimaging studies for restless legs syndrome and periodic leg movement disorder].

Authors:  S Happe; W Paulus
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

3.  Genetic markers of Restless Legs Syndrome in Parkinson disease.

Authors:  Ziv Gan-Or; Roy N Alcalay; Anat Bar-Shira; Claire S Leblond; Ronald B Postuma; Shay Ben-Shachar; Cheryl Waters; Amelie Johnson; Oren Levy; Anat Mirelman; Mali Gana-Weisz; Nicolas Dupré; Jacques Montplaisir; Nir Giladi; Stanley Fahn; Lan Xiong; Patrick A Dion; Avi Orr-Urtreger; Guy A Rouleau
Journal:  Parkinsonism Relat Disord       Date:  2015-03-17       Impact factor: 4.891

Review 4.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

5.  Prevalence of restless legs syndrome and sleep quality in carriers of the fragile X premutation.

Authors:  S M Summers; J Cogswell; J E Goodrich; Y Mu; D V Nguyen; S D Brass; R J Hagerman
Journal:  Clin Genet       Date:  2014-08       Impact factor: 4.438

6.  [Practical guidelines for diagnosis and therapy of restless legs syndrome].

Authors:  M Krenzer; W Oertel; C Trenkwalder
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

7.  Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease.

Authors:  D L Bliwise; L M Trotti; J A Yesavage; D B Rye
Journal:  Eur J Neurol       Date:  2012-02-16       Impact factor: 6.089

8.  Elevated estradiol plasma levels in women with restless legs during pregnancy.

Authors:  Andrea Dzaja; Renate Wehrle; Marike Lancel; Thomas Pollmächer
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

Review 9.  Treatment of restless legs syndrome.

Authors:  Cynthia L Comella
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

10.  Increased synaptic dopamine in the putamen in restless legs syndrome.

Authors:  Christopher J Earley; Hiroto Kuwabara; Dean F Wong; Charlene Gamaldo; Rachel E Salas; James R Brašić; Hayden T Ravert; Robert F Dannals; Richard P Allen
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.